Download
document (9).pdf 170,62KB
WeightNameValue
1000 Titel
  • Digital Image Analysis Of Her2 Immunostained Gastric And Gastroesophageal Junction Adenocarcinomas : SY01.06 | Image Analysis I
1000 Autor/in
  1. Nielsen, S.L. |
  2. Nielsen, S. |
  3. Vyberg, Mogens |
1000 Erscheinungsjahr 2016
1000 Publikationstyp
  1. Kongressschrift |
  2. Artikel |
1000 Online veröffentlicht
  • 2016-06-08
1000 Erschienen in
1000 Quellenangabe
  • 1(8):120
1000 Übergeordneter Kongress
1000 Copyrightjahr
  • 2016
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.17629/www.diagnosticpathology.eu-2016-8:120 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • INTRODUCTION / BACKGROUND: Manual assessment of HER2 protein expression in gastric and gastroesophageal junction (GGEJ) adenocarcinomas is prone to inter-observer variability and hampered by tumor heterogeneity and different scoring criteria. Cases are frequently referred to FISH. AIMS: This study aimed to evaluate the accuracy of digital image analysis (DIA) for the assessment of HER2 protein expression. METHODS: 110 GGEJ adenocarcinomas were included in TMAs with 3 tissue cores per case. Two immunoassays, PATHWAY® and HercepTest™, and FISH were performed. The HER2 CONNECT™ DIA software as designed for breast carcinoma was applied. Connectivity, calculated by the software, was converted to standard IHC scores applying predetermined cut-off values for breast carcinoma as well as novel cut-off values. RESULTS: Applying HER2 CONNECT™ with established connectivity cut-off values designed for breast carcinoma resulted in 72.7% sensitivity and 100% specificity for the identification of HER2 positive cases. By application of new cut-off values, the sensitivity was increased to 100%, while the specificity remained 100%. With the new cut-off values, a 36-50% reduction of IHC equivocal cases requiring additional FISH analysis was observed. Conclusion: HER2 CONNECT™ with adjusted cut-off values seems to be an effective tool for the assessment of HER2 protein expression in GGEJ adenocarcinomas, allowing for a decreased need for FISH analyses.
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TmllbHNlbiwgUy5MLg==|https://frl.publisso.de/adhoc/uri/TmllbHNlbiwgUy4=|https://frl.publisso.de/adhoc/uri/VnliZXJnLCBNb2dlbnM=
1000 Label
1000 Förderer
  1. Verein für den biol. technol. Fortschritt in der Medizin, Heidelberg |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Verein für den biol. technol. Fortschritt in der Medizin, Heidelberg |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6431582.rdf
1000 Erstellt am 2022-02-15T15:24:26.572+0100
1000 Erstellt von 218
1000 beschreibt frl:6431582
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet 2022-08-18T13:05:04.821+0200
1000 Objekt bearb. Thu Aug 18 12:38:50 CEST 2022
1000 Vgl. frl:6431582
1000 Oai Id
  1. oai:frl.publisso.de:frl:6431582 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source